Regencell Bioscience Limited
RGC | NASDAQ
$6.17
+$0.25 (+4.22%)
Sep 22, 2026, 2:46 PM ET · Market open
Company Profile
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Key Executives
| Name | Position |
|---|---|
| Yat-Gai Au | Founder, Chairman & Chief Executive Officer |
| Michelle Chan | Financial Controller, Chief Financial Officer & Principal Financial Officer |
| Wai Hong Chung | Chief Operating Officer, Chief Strategy Officer & Director |
| Antonia Assang | Senior Vice President of Project Management |
| Yat-Pui Au | Chief Business Officer |
Regencell Bioscience Limited
| Country | Hong Kong SAR China |
| IPO Date | Jul 15, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 10 |
| CEO | Yat-Gai Au |
Contact Details
Chinachem Leighton Plaza Hong Kong KY1-1107 Hong Kong SAR China
Stock Details
| Ticker Symbol | RGC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001829667 |
| CUSIP Number | G7487R100 |
| ISIN Number | KYG7487R1002 |
| SIC Code | 2833 |
Recent News
- 1 month ago / seekingalpha.comRGC Resources: More Likely To Appeal More To Income-Focused Investors
- 2 months ago / marketbeat.comRGC Resources Q3 Earnings Call Highlights
- 3 months ago / seekingalpha.comUnited Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises
- 3 months ago / globenewswire.comRGC Resources, Inc. Declares Quarterly Dividend
- 3 months ago / globenewswire.comPomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limitedand Certain Officers – RGC
- 3 months ago / prnewswire.comBronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
- 3 months ago / gurufocus.comRegencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
- 3 months ago / globenewswire.comPortnoy Law Firm Announces Class Action on Behalf of Regencell Bioscience Holdings Limited Investors
- 3 months ago / prnewswire.comRGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The Gross Law Firm
- 3 months ago / prnewswire.comRGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit
Add to Watchlist
Select watchlists to add or remove RGC